Align Technology Inc
What Wall Street Analysts Recommend for Dentsply Sirona
Dentsply Sirona (XRAY), one of the leading dental technology providers in the United States, recently outlined a turnaround plan to recover from the company’s disappointing performance in recent years.
ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain
On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.
Align Technology Traded at Its 52-Week High in September
Align Technology was trading at its 52-week high of $398.88 on September 25. The stock reported its 52-week low of $180.31 on September 28, 2017.
Wall Street Analysts Are Still Bullish on ALGN Stock
Align Technology (ALGN) stock hasn’t received any recommendation updates since the stock was upgraded by several analysts in July.
Will Dentsply Sirona Stock Recover from Recent Declines?
On April 6, 2018, Dentsply Sirona (XRAY) ended at a closing price of $49.02 per share.
Analysts Cut Their Targets for XRAY ahead of Its 1Q18 Results
Dentsply Sirona, one of the leading dental technology providers in the United States, will announce its 1Q18 earnings results on May 7.
Align Stock Jumps After Q3 Earnings Call
Renaissance Technologies: Analyzing Its Q3 13F
At the end of the third quarter, Bristol-Myers Squibb, Celgene, Biogen, UnitedHealth, and Walmart (WMT) were Renaissance Technologies’ top five buys.
Align Technology Stock Recovers after Tanking Last Week
Align Technology stock (ALGN) took a massive hit after Q2 earnings. So what was behind the massive decline, and what’s helping the stock recover?
Align Technology Disappoints Investors with Reduced Guidance
Yesterday, Align Technology (ALGN) reported its second-quarter earnings results after the market closed.
Align Technology: What to Expect in Q2
Align Technology (ALGN) plans to release its second-quarter earnings on July 24 after the market closes.
Powell’s Testimony Drives US Stock Market to All-Time High
This morning, US index futures surged after Federal Reserve Chair Jerome Powell’s testimony raised the possibility of a near-term cut in interest rates.
How These Medical Equipment Stocks Have Fared in the Last Month
In December 2018, of the total 15 analysts covering Align Technology, 13 analysts have given the stock a “buy” or higher rating.
Taking Stock of Edwards Lifesciences’ Performance
A strong operational performance and steady uptick in Edwards Lifesciences’ stock price has kept investors interested in the stock in 2018.
Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date
Intuitive Surgical’s stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018.
What Does Dentsply’s Bottom-Line Trend Indicate?
Dentsply Sirona’s interest expense decreased marginally from $9.8 million in the third quarter of 2017 to $9.7 million in the third quarter.
How Wall Street Analysts View TransEnterix
Of the five analysts tracking TransEnterix in July, two of them have recommended a “strong buy,” and one has recommended a “buy.”
20 Earnings Reports to Watch for This Week
Earnings season is in full swing, and the week of April 23 is jam-packed with releases by some of the market’s most popular companies. Here are 20 reports we will be watching closely next week: Monday, April 23: Hasbro, Inc. (NASDAQ: HAS) – before the market opens -will they say anything about Mattel with the […]
Here’s What Dentsply Sirona Has Planned for Its Margins
Dentsply Sirona has a new management team that is working toward a more successful integration because it delivered lower-than-expected synergies in 2017.
Understanding Dentsply Sirona’s New Organizational Structure
In 4Q17, Dentsply Sirona (XRAY) started reporting its operations under two segments, after a shift to three segments in fiscal 3Q17.
Reading Dentsply Sirona’s Recent Stock Performance
On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.
Why Is Wall Street Still Upbeat on Dentsply Sirona’s Growth Potential in 2018?
Dentsply Sirona is a leading dental technology, equipment, and consumables provider in the US. But it has been going through some tough times.
Align Technology and Its SmileDirectClub Partnership
In 4Q17, Align Technology reported a sequential decline in its shipments of non-Invisalign SDC aligners to SDC.
Align Technology to Execute on Key Strategic Priorities in 2018
Align Technology (ALGN) has been growing at a fast pace while it executes its strategic priorities around the world.
Align Technology’s Invisalign: Average Selling Price and Volumes
Increases in Align Technology’s (ALGN) Invisalign volumes and ASP were the major factors driving the company’s sales growth.
Align Technology: Analyst Ratings and Recommendations
Of the 12 investment research firms following ALGN stock, ten of them have given the stock “buy” or “strong buy” recommendations.
Inside Abbott Laboratories’ 4Q17 Earnings Results: Key Highlights
Abbott Laboratories (ABT) reported sales of $7.6 billion and adjusted diluted EPS (earnings per share) of $0.74 for fiscal 4Q17.
Wall Street Issues Majority ‘Buy’ Ratings on Align Technology
On December 29, 2017, according to 12 investment brokerage firms which were part of a Reuters survey, Align Technology stock has received a “buy” rating from 11 analysts.
Align Technology’s Customer Acquisition Strategy Driving Market Growth
In 3Q17, Align Technology trained nearly 1,000 doctors in China.
Align Technology’s Growth Prospects amid Increasing Competition
The Chinese market is Align Technology’s major growth driver. However, the company is starting to witness strong competition from startups focused on the clear aligners market.
Dental and Healthcare Consumables Grew but Missed Expectations in 2Q17
In 2Q17, Dentsply Sirona’s (XRAY) Dental and Healthcare Consumables business contributed ~56% to the company’s total revenues and registered sales of ~$554 million.
Align Technology Focuses on International Market Strategy
International market strategy In 2Q17, Align Technology (ALGN) reported 85,400 Invisalign case shipments in international markets, which is YoY (year-over-year) growth of ~37.4% and sequential growth of ~13.6%. This growth was mainly attributed to new customers in the EMEA (Europe, the Middle East, and Africa) and Asia-Pacific markets. If Align Technology continues to demonstrate solid […]
Inside Align Technology’s Market Expansion Strategy
In 1Q17, Align Technology (ALGN) also witnessed a robust rise of around 45.2% in volumes of Invisalign sold in Asia-Pacific markets on a YoY basis.
Understanding Align Technology’s Growing Position in International Markets
In 1Q17, Align Technology (ALGN) witnessed an 11.4% sequential rise in the volume of Invisalign cases used by doctors in international markets.
These Are Align Technologies Key Demand Drivers in North America
In 1Q17, Align Technology (ALGN) has started selling its new product Invisalign Go in North America, which involves a few DSOs (dental service organizations).
Behind Align Technology’s North American Expectations for 2017
In 1Q17, Align Technology’s (ALGN) Invisalign sales volumes in North American markets rose YoY by 20.3% and QoQ by 8.3%.
Why Align Technology’s Orthodontics Is a Solid Growth Opportunity in 2017
Align Technology (ALGN) is a medical device provider focused on malocclusion or teeth misalignment condition.
Inside Align Technology’s Robust Revenue Growth Projection for 2017
For fiscal 2017, Align Technology (ALGN) expects its 2017 revenues to grow operationally in the range of 15%–25% YoY.
Align Technology versus Peers in June 2017: Analyst Recommendations
For 1Q17, Align Technology (ALGN) reported revenues close to $310.3 million, which represents YoY (year-over-year) growth of around 30.0%.
How Dentsply Sirona’s Profitability Metrics Looked in 1Q17
Dentsply Sirona’s (XRAY) 1Q17 earnings and revenue failed to meet analysts’ estimates. The company reported a fall in its organic revenue.
The Larger Aims of Obamacare: An Overview
The idea behind Obamacare was that it would embody legislation not only providing but mandating healthcare coverage for nearly everyone in the US.
What Are Analysts’ Recommendations for Dentsply Sirona?
According to a Bloomberg survey, 43% of the analysts gave Dentsply Sirona a “buy” rating and ~57% gave it a “hold” rating. It didn’t have any “sell” ratings.
Why Is Dentsply Sirona Acquiring MIS Implants?
Dentsply Sirona is acquiring MIS due to its established brand and broad portfolio of implants and related products.
A Brief Look at Dentsply Sirona’s Business Model
Dentsply Sirona (XRAY) offers a broad portfolio of dental equipment and consumables that have urological and surgical applications.
Introducing Dentsply Sirona, a Leading Dental Products Manufacturer
Dentsply Sirona (XRAY) is the largest manufacturer of dental equipment and technologies in the world. The company was formed in February 2016.
Analyzing Sirona Dental Systems’ Rise in Revenue in Fiscal 4Q15
After the release of Sirona Dental Systems’ (SIRO) 4Q15 earnings report, SIRO rose by 0.23% to close at $109.22 per share on November 20, 2015.
How Does Dentsply International Compare to Peers after 3Q15?
In this article, we’ll compare Dentsply against its peers and the ETFs that invest in Dentsply.